Literature DB >> 35274212

To quantify or not to quantify, that is the question: Semi-quantitative vs. visual analysis of Rb-82 myocardial perfusion imaging PET.

Christoph Rischpler1,2, David Kersting3, Stephan G Nekolla4,5.   

Abstract

Entities:  

Year:  2022        PMID： 35274212     DOI： 10.1007/s12350-022-02935-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  11 in total

Review 1.  The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis.

Authors:  Louise D Metz; Mary Beattie; Robert Hom; Rita F Redberg; Deborah Grady; Kirsten E Fleischmann
Journal:  J Am Coll Cardiol       Date:  2006-12-29       Impact factor: 24.094

2.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

3.  Ischemia burden on stress SPECT MPI predicts long-term outcomes after revascularization in stable coronary artery disease.

Authors:  Hendrik J Boiten; Jan C van den Berge; Roelf Valkema; Ron T van Domburg; Felix Zijlstra; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2016-11-29       Impact factor: 5.952

4.  Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker.

Authors:  Christoph Rischpler; Takahiro Higuchi; Kenji Fukushima; Mehrbod S Javadi; Jennifer Merrill; Stephan G Nekolla; Paco E Bravo; Frank M Bengel
Journal:  J Nucl Med       Date:  2012-04-09       Impact factor: 10.057

5.  Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) Study.

Authors:  Gregory S Thomas; Michael I Miyamoto; A Peter Morello; Haresh Majmundar; Jennifer J Thomas; Christine H Sampson; Rory Hachamovitch; Leslee J Shaw
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

Review 6.  Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis.

Authors:  Brian A Mc Ardle; Taylor F Dowsley; Robert A deKemp; George A Wells; Rob S Beanlands
Journal:  J Am Coll Cardiol       Date:  2012-10-03       Impact factor: 24.094

7.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Influence of 99mTc-tetrofosmin SPECT myocardial perfusion imaging on the prediction of future adverse cardiac events.

Authors:  Diwakar Jain; Harry Lessig; Riti Patel; Leonard Sandler; Fred Weiland; Steven L Edell; M Elizabeth Oates; Erin O'Malley-Tysko; Natalie Khutoryansky; Arnold F Jacobson
Journal:  J Nucl Cardiol       Date:  2009-04-24       Impact factor: 5.952

9.  Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease.

Authors:  R Parkash; R A deKemp; T D Ruddy; A Kitsikis; R Hart; L Beauchesne; L Beauschene; Kathryn Williams; R A Davies; M Labinaz; R S B Beanlands
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

10.  Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.

Authors:  Caroline Jaarsma; Tim Leiner; Sebastiaan C Bekkers; Harry J Crijns; Joachim E Wildberger; Eike Nagel; Patricia J Nelemans; Simon Schalla
Journal:  J Am Coll Cardiol       Date:  2012-05-08       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.